砷
医学
疾病
环境卫生
砷毒性
氧化应激
不利影响
生理学
毒性
内科学
冶金
材料科学
作者
М И Кононенко,William H. Frishman
出处
期刊:Cardiology in Review
[Ovid Technologies (Wolters Kluwer)]
日期:2020-09-15
卷期号:29 (4): 217-221
被引量:11
标识
DOI:10.1097/crd.0000000000000357
摘要
Arsenic is a ubiquitously dispersed metalloid that has been implicated as the cause of various adverse health effects. Human exposure to arsenic primarily occurs through contaminated drinking water and dietary intake of rice and grains, posing a great public health risk to millions of people worldwide. High levels of arsenic have been positively associated with incident cardiovascular disease (CVD). In the last decade, a growing body of evidence has established a role for low-to-moderate arsenic exposure in CVD risk as well. The molecular mechanism of action by which arsenic induces cardiovascular toxicity is not completely understood, but epigenetic changes, increased platelet aggregation, and increased oxidative stress have all been implicated. Presently, there is a substantial amount of retrospective and prospective cohort studies supporting the role of arsenic in CVD, although randomized controlled trials have yet to be conducted. In this review, we have sought to summarize the existing high-quality evidence elucidating arsenic's role in CVD development and to evaluate the need for future research.
科研通智能强力驱动
Strongly Powered by AbleSci AI